Oleamide is a documented neuroactive fatty-acid amide that reverses scopolamine-induced cognitive impairment and restores cholinergic function, which aligns with its moderate docking to ACHE/CHRM1 in our dataset and the enrichment of synaptic receptor pathways [18]. The gene discussed is CHRM1; the disease is Cognitive impairment.